98 related articles for article (PubMed ID: 21412928)
1. High-resolution array CGH identifies common mechanisms that drive embryonal rhabdomyosarcoma pathogenesis.
Paulson V; Chandler G; Rakheja D; Galindo RL; Wilson K; Amatruda JF; Cameron S
Genes Chromosomes Cancer; 2011 Jun; 50(6):397-408. PubMed ID: 21412928
[TBL] [Abstract][Full Text] [Related]
2. Atypical neurofibromas in neurofibromatosis type 1 are premalignant tumors.
Beert E; Brems H; Daniëls B; De Wever I; Van Calenbergh F; Schoenaers J; Debiec-Rychter M; Gevaert O; De Raedt T; Van Den Bruel A; de Ravel T; Cichowski K; Kluwe L; Mautner V; Sciot R; Legius E
Genes Chromosomes Cancer; 2011 Dec; 50(12):1021-32. PubMed ID: 21987445
[TBL] [Abstract][Full Text] [Related]
3. Molecular characterization of 9p21 deletions shows a minimal common deleted region removing CDKN2A exon 1 and CDKN2B exon 2 in diffuse large B-cell lymphomas.
Guney S; Bertrand P; Jardin F; Ruminy P; Kerckaert JP; Tilly H; Bastard C
Genes Chromosomes Cancer; 2011 Sep; 50(9):715-25. PubMed ID: 21638516
[TBL] [Abstract][Full Text] [Related]
4. Frequent loss of chromosome 9, homozygous CDKN2A/p14(ARF)/CDKN2B deletion and low TSC1 mRNA expression in pleomorphic xanthoastrocytomas.
Weber RG; Hoischen A; Ehrler M; Zipper P; Kaulich K; Blaschke B; Becker AJ; Weber-Mangal S; Jauch A; Radlwimmer B; Schramm J; Wiestler OD; Lichter P; Reifenberger G
Oncogene; 2007 Feb; 26(7):1088-97. PubMed ID: 16909113
[TBL] [Abstract][Full Text] [Related]
5. Frequent deletion of CDKN2A and recurrent coamplification of KIT, PDGFRA, and KDR in fibrosarcoma of bone--an array comparative genomic hybridization study.
Niini T; López-Guerrero JA; Ninomiya S; Guled M; Hattinger CM; Michelacci F; Böhling T; Llombart-Bosch A; Picci P; Serra M; Knuutila S
Genes Chromosomes Cancer; 2010 Feb; 49(2):132-43. PubMed ID: 19862822
[TBL] [Abstract][Full Text] [Related]
6. CDKN2A/B alterations impair prognosis in adult BCR-ABL1-positive acute lymphoblastic leukemia patients.
Iacobucci I; Ferrari A; Lonetti A; Papayannidis C; Paoloni F; Trino S; Storlazzi CT; Ottaviani E; Cattina F; Impera L; Abbenante MC; Vignetti M; Vitale A; Potenza L; Paolini S; Soverini S; Pane F; Luppi M; Foà R; Baccarani M; Martinelli G
Clin Cancer Res; 2011 Dec; 17(23):7413-23. PubMed ID: 22134481
[TBL] [Abstract][Full Text] [Related]
7. Genomic imbalances in rhabdomyosarcoma cell lines affect expression of genes frequently altered in primary tumors: an approach to identify candidate genes involved in tumor development.
Missiaglia E; Selfe J; Hamdi M; Williamson D; Schaaf G; Fang C; Koster J; Summersgill B; Messahel B; Versteeg R; Pritchard-Jones K; Kool M; Shipley J
Genes Chromosomes Cancer; 2009 Jun; 48(6):455-67. PubMed ID: 19235922
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous aberrations of single CDKN2A network components and a high Rb phosphorylation status can differentiate subgroups of primary cutaneous B-cell lymphomas.
Kaune KM; Neumann C; Hallermann C; Haller F; Schön MP; Middel P
Exp Dermatol; 2011 Apr; 20(4):331-5. PubMed ID: 21410763
[TBL] [Abstract][Full Text] [Related]
9. Chromosomal and genetic imbalances in Chinese patients with rhabdomyosarcoma detected by high-resolution array comparative genomic hybridization.
Liu C; Li D; Hu J; Jiang J; Zhang W; Chen Y; Cui X; Qi Y; Zou H; Zhang W; Li F
Int J Clin Exp Pathol; 2014; 7(2):690-8. PubMed ID: 24551291
[TBL] [Abstract][Full Text] [Related]
10. Anaplastic lymphoma kinase aberrations in rhabdomyosarcoma: clinical and prognostic implications.
van Gaal JC; Flucke UE; Roeffen MH; de Bont ES; Sleijfer S; Mavinkurve-Groothuis AM; Suurmeijer AJ; van der Graaf WT; Versleijen-Jonkers YM
J Clin Oncol; 2012 Jan; 30(3):308-15. PubMed ID: 22184391
[TBL] [Abstract][Full Text] [Related]
11. Gains, losses, and amplification of genomic material in rhabdomyosarcoma analyzed by comparative genomic hybridization.
Weber-Hall S; Anderson J; McManus A; Abe S; Nojima T; Pinkerton R; Pritchard-Jones K; Shipley J
Cancer Res; 1996 Jul; 56(14):3220-4. PubMed ID: 8764111
[TBL] [Abstract][Full Text] [Related]
12. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
Worsham MJ; Chen KM; Tiwari N; Pals G; Schouten JP; Sethi S; Benninger MS
Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):409-15. PubMed ID: 16618910
[TBL] [Abstract][Full Text] [Related]
13. Role of noncoding RNA ANRIL in genesis of plexiform neurofibromas in neurofibromatosis type 1.
Pasmant E; Sabbagh A; Masliah-Planchon J; Ortonne N; Laurendeau I; Melin L; Ferkal S; Hernandez L; Leroy K; Valeyrie-Allanore L; Parfait B; Vidaud D; Bièche I; Lantieri L; Wolkenstein P; Vidaud M;
J Natl Cancer Inst; 2011 Nov; 103(22):1713-22. PubMed ID: 22034633
[TBL] [Abstract][Full Text] [Related]
14. Genetic heterogeneity in rhabdomyosarcoma revealed by SNP array analysis.
Walther C; Mayrhofer M; Nilsson J; Hofvander J; Jonson T; Mandahl N; Øra I; Gisselsson D; Mertens F
Genes Chromosomes Cancer; 2016 Jan; 55(1):3-15. PubMed ID: 26482321
[TBL] [Abstract][Full Text] [Related]
15. Myc oncogene expression and nude mouse tumorigenicity and metastasis formation are higher in alveolar than embryonal rhabdomyosarcoma cell lines.
Kouraklis G; Triche TJ; Wesley R; Tsokos M
Pediatr Res; 1999 Apr; 45(4 Pt 1):552-8. PubMed ID: 10203148
[TBL] [Abstract][Full Text] [Related]
16. Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas.
Boström J; Meyer-Puttlitz B; Wolter M; Blaschke B; Weber RG; Lichter P; Ichimura K; Collins VP; Reifenberger G
Am J Pathol; 2001 Aug; 159(2):661-9. PubMed ID: 11485924
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of methylthioadenosin phosphorylase by homozygous deletion in gastric carcinoma.
Kim J; Kim MA; Min SY; Jee CD; Lee HE; Kim WH
Genes Chromosomes Cancer; 2011 Jun; 50(6):421-33. PubMed ID: 21412930
[TBL] [Abstract][Full Text] [Related]
18. Cytodifferentiation and clinical outcome after chemotherapy and radiation therapy for rhabdomyosarcoma (RMS).
Smith LM; Anderson JR; Coffin CM
Med Pediatr Oncol; 2002 Jun; 38(6):398-404. PubMed ID: 11984800
[TBL] [Abstract][Full Text] [Related]
19. Analysis of cyclin-dependent kinase inhibitor genes (CDKN2A, CDKN2B, and CDKN2C) in childhood rhabdomyosarcoma.
Iolascon A; Faienza MF; Coppola B; Rosolen A; Basso G; Della Ragione F; Schettini F
Genes Chromosomes Cancer; 1996 Apr; 15(4):217-22. PubMed ID: 8703847
[TBL] [Abstract][Full Text] [Related]
20.
de Traux de Wardin H; Dermawan JK; Vanoli F; Jiang SC; Singer S; Chi P; Tap W; Wexler LH; Antonescu CR
JCO Precis Oncol; 2024 Apr; 8():e2300597. PubMed ID: 38603649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]